510(k) Report

510(k) · Cleared

Recalled · Class II · 2015

Cobas B 123 Poc System, Cobas B 123 Autoqc Pack Tri-Level, Cobas B 123 Autocvc Pack, Roche Combitrol Plus B

K111188510(k) TraditionalCleared May 14, 2012383-day reviewClass II21 CFR 862.1120Recalls 4

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics · CHL Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph

Cleared on May 14, 2012 as substantially equivalent to K032311 (Roche Diagnostics Corp., 2003) and 3 other predicates after a 383-day review. Its family tree reaches back 4 generations to 1994. It has been recalled 4 times.

Decided
May 14, 2012
Review
383 days
Class
Class II
Product code
CHL
Recalls
4
Predicates
4

Its longest line of descent runs back 4 generations to K940918 (1994). 11 ancestors in all, the oldest K913133 (1991). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2006: 1 other ancestor2003: 1 other ancestor1992: 1 other ancestor1996: 2 other ancestors1995: 1 other ancestor1991: 1 other ancestorK940918 · I-Stat 200 Portable Clinical Analyzer · I-Stat Corp. · 1994 · recalledK990092 · Avl Omni Modular Analyzer · Avl Scientific Corp. · 1999 · recalledK013373 · Omni C Analyzer · Roche Diagnostics Corp. · 2001 · recalledK032311 · Roche Diagnostics Omni S Analyzer · Roche Diagnostics Corp. · 2003 · recalled19901995200020052010
  1. Root · 4 generations backK940918 I-Stat 200 Portable Clinical AnalyzerI-Stat Corp. · 1994 · Recalled
  2. 3 generations backK990092 Avl Omni Modular AnalyzerAvl Scientific Corp. · 1999 · Recalled
  3. 2 generations backK013373 Omni C AnalyzerRoche Diagnostics Corp. · 2001 · Recalled
  4. 1 generation backK032311 Roche Diagnostics Omni S AnalyzerRoche Diagnostics Corp. · 2003 · Recalled
  5. This deviceK111188 Cobas B 123 Poc System, Cobas B 123 Autoqc Pack Tri-Level, Cobas B…Roche Diagnostics · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K940918I-Stat 200 Portable Clinical AnalyzerI-Stat Corp.199419
−3K990092Avl Omni Modular AnalyzerAvl Scientific Corp.19994
−2K013373Omni C AnalyzerRoche Diagnostics Corp.20011
−1K032311Roche Diagnostics Omni S AnalyzerRoche Diagnostics Corp.20039
0 (this device)K111188Cobas B 123 Poc System, Cobas B 123 Autoqc Pack Tri-Level, Cobas B 123 Autocvc…Roche Diagnostics2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199210
199510
199620
200310
200610
FIG. 1 — Lineage of K111188, 1994–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CHL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CHL device

  1. #1 K252207 ABL90 FLEX PLUS System, safeCLINITUBESscore 14.1 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K032311Roche Diagnostics Omni S Analyzer
Summary page 7
…intended for similar use. We claim equivalency to the following currently marketed products: * cobas b 221 (OMNI S) Blood Gas System-K03231 1 *Hitachi 902 Analyzer (Glucose and Lactate)-K92 1661 *cobas c 501 Analyzer (Glucose and.…
Roche Diagnostics Corp.20039
*K921661Boehringer Mannheim/ Hitachi 911 Analyzer
Summary page 7
…llowing currently marketed products: * cobas b 221 (OMNI S) Blood Gas System-K03231 1 *Hitachi 902 Analyzer (Glucose and Lactate)-K92 1661 *cobas c 501 Analyzer (Glucose and. Lactate)-K060373/AO1 *COMBITROL PLUS B /AUTOTROL PLUS…
Boehringer Mannheim Corp.19921
*K060373Cobas 6000 Series System
Summary page 7
…NI S) Blood Gas System-K03231 1 *Hitachi 902 Analyzer (Glucose and Lactate)-K92 1661 *cobas c 501 Analyzer (Glucose and. Lactate)-K060373/AO1 *COMBITROL PLUS B /AUTOTROL PLUS B-K032453…
Roche Diagnostics200610
*K032453Roche Combitrol and Autotrol Plus B Multi Analyte Control
Summary page 7
…alyzer (Glucose and Lactate)-K92 1661 *cobas c 501 Analyzer (Glucose and. Lactate)-K060373/AO1 *COMBITROL PLUS B /AUTOTROL PLUS B-K032453 Continued on next page Confidential…
Bionostics, Inc.2003—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 3, 2015Class IIZ-1077-2017Software designunder specific settings, an issue may occur during simultaneous Sensor Cartridge and Fluid Pack change on the cobas b 123 <2> POC system and cobas b 123 <4> POC system. The issue occurs when the software function [AutoQC as follow-up] is…
Jul 14, 2015Class IIZ-2446-2015Nonconforming Material/ComponentLow PO2 results. QC failures of the PO2 parameter, affecting primarily Levels 1 and 2, caused by a calibration issue with the PO2 parameter. This issue may not be detected since QC results can be below mean values, but still within 2…
Jul 14, 2015Class IIZ-2447-2015Nonconforming Material/ComponentLow PO2 results. QC failures of the PO2 parameter, affecting primarily Levels 1 and 2, caused by a calibration issue with the PO2 parameter. This issue may not be detected since QC results can be below mean values, but still within 2…
Nov 14, 2012Class IIZ-0522-2013Software design (manufacturing process)It has been determined that cobas b 123 Fluid Pack COOX cuvettes for lot numbers 21426121 and 21426171, exhibit a significant increase in the out-of-box failure rate caused by a change in the thickness in the cuvette layer. Internal…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 4 companies; a new generation was cleared every 4.7 years on median.
  • 8 of the 11 ancestors have a recall of any class.

How does its category compare?

All CHL devices

CHL Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · CHL

1in 2025

2007: 12008: 12010: 12011: 42012: 42013: 52014: 32015: 42016: 32017: 12018: 12020: 42021: 22023: 52024: 12025: 12026 (partial year): 1
2007high 5 (2013) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CHL

267in 2023

2011: 108 days median2012: 65 days median2013: 152 days median2014: 68 days median2015: 155 days median2016: 306 days median2020: 100 days median2023: 267 days median
2007high 306 (2016) · low 65 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CHL

13so far in 2026, the most since 2007

2007: 62008: 52009: 62010: 72011: 12012: 92013: 12014: 12015: 32016: 12017: 12018: 32020: 22023: 42024: 92026 (partial year): 13
2007high 13 (2026) · low 0 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CHL

210in 2025

2007: 162008: 402009: 742010: 202011: 502012: 642013: 622014: 932015: 552016: 1182017: 2062018: 1742019: 1412020: 1172021: 1472022: 1382023: 1772024: 1962025: 210
2007high 210 (2025) · low 16 (2007)2025

MAUDE reports naming product code CHL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—616
20081—540
20090—674
20101—720
20114108150
2012465964
20135152162
2014368193
20154155355
201633061118
20171—1206
20181—3174
20190—0141
202041002117
20212—0147
20220—0138
202352674177
20241—9196
20251—0210
20261—13—

What is it indicated for?

The cobas b 123 POC system is a fully automated POC system for whole blood in vitro measurement of pH, blood gases (BG), electrolytes Na', K*, iCa2* (ISE), hematocrit (Hct), metabolites (Glu, Lac), total hemoglobin (tHb), hemoglobin derivatives (O2 Hb, HHb, COHb, MetHb), and oxygen saturation (SO 2) In addition, the cobas b 123 POC system calculates derived parameters. It is dedicated for use in a Point-of-Care environment and laboratory. The integrated…

Read the full statement (562 words)

The cobas b 123 POC system is a fully automated POC system for whole blood in vitro measurement of pH, blood gases (BG), electrolytes Na', K*, iCa2* (ISE), hematocrit (Hct), metabolites (Glu, Lac), total hemoglobin (tHb), hemoglobin derivatives (O2 Hb, HHb, COHb, MetHb), and oxygen saturation (SO 2) In addition, the cobas b 123 POC system calculates derived parameters.

It is dedicated for use in a Point-of-Care environment and laboratory. The integrated AutoQC module and the oximeter module are available as an option.

PH, P02 and PCO 2 : PH, P0 2 and PCO 2 measurements are used in the diagnosis and treatment of life-threatening acid-base disturbances.

Sodium (Na 4 ): sodium measurements are used in the diagnosis and treatment of aldosteronism, diabetes insipidus, adrenal hypertension, Addison's disease, dehydration, inappropriate antidiuretic secretion, or other diseases involving electrolyte imbalance.

Potassium (K1 ): potassium measurements are used to monitor electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels.

Calcium (Ca 2"): calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms).

Hematocrit (Het): hematocrit measurements are used to distinguish normal from abnormal states of whole blood, such as anemia and erythrocytosis (an increase in the number of red cells).

Glucose (Glu): glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus and idiopathic hypoglycemnia, and of pancreatic. islet cell carcinoma.,

Lactate (Lac): Lactate measurements are used to evaluate the acid-base status and are used in the diagnosis and treatment of lactic acidosis (abnormally high acidity of the blood.)

Total Hemoglobin (tHb): total hemoglobin measurements are used to measure the hemoglobin content of whole blood for the detection of anemia.

O2Hb: oxyhemoglobin as a fraction of total hemoglobin.

COHb: carboxyhemoglobin measurements are used to determine the carboxyhemoglobin content of human blood as an aid in the diagnosis of carbon monoxide poisoning.

Meti-b: methemoglobin as a fraction of total hemoglobin.

HHb: reduced hemoglobin as a fraction of total hemoglobin.

SO 2 : oxygen saturation, more specifically the ratio between the concentration of oxyhemoglobin and oxyhemoglobin plus reduced hemoglobin.

The cobas b 123 AutoQC pack Tni-Level is a multi-analyte control intended for use as control material to monitor the measurement of PH, PCO2 , P0 2 , SO2 , Nat, K+, iCa2+, Hct, tHb and Hb derivatives as well as glucose and lactate on cobas b 123 systems with an AutoQC module.

The cobas b 123 AutoCVC Pack is a multi-analyte control, intended for use in calibration verification of the measuring range established by the cobas b 123 POC system for PH, PCO2 , P0 2 , SO2 , Nat, K+, iCa 2 +,Hct, tHb and Hb derivatives as well as glucose and lactate on cobas b 123 systems with an AutoQC module.

COMBITROL PLUS B is a multi-analyte control intended for use as control material to monitor the measurement of pH, PCO2 , P0 2 , SO 2, Nat; Kt., CE, iCa 2 +,Uct, ti-b and Hb derivatives as well as glucose, lactate, urea/BUN and bilirubin on Roche OMNI S or cobas b 221 analyzers with an oximeter module, and cobas b 123 analyzers (except urea/BUN, chloride, and bilirubin). COMBITROL PLUS B control material is not intended for use with analyzers from other manufacturers.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K111188: Cobas B 123 Poc System, Cobas B 123 Autoqc Pack Tri-Level, Cobas B 123 Autocvc Pack, Roche Combitrol Plus B.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K111188

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026